Country: Ирска
Језик: Енглески
Извор: HPRA (Health Products Regulatory Authority)
Eplerenone
Imbat Limited
C03DA; C03DA04
Eplerenone
50 milligram(s)
Film-coated tablet
Product subject to prescription which may be renewed (B)
Aldosterone antagonists; eplerenone
Authorised
2013-09-13
Page 1 of 2 PACKAGE LEAFLET: INFORMATION FOR THE USER INSPRA ® 50MG FILM-COATED TABLETS (eplerenone) Your medicine is available using the above name but will be referred to as INSPRA throughout this leaflet. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What INSPRA is and what it is used for 2. What you need to know before you take INSPRA 3. How to take INSPRA 4. Possible side effects 5. How to store INSPRA 6. Contents of the pack and other information 1. WHAT INSPRA IS AND WHAT IT IS USED FOR INSPRA belongs to a group of medicines known as selective aldosterone blocking agents. These blocking agents inhibit the action of aldosterone, a substance produced within the body, which controls your blood pressure and heart function. High levels of aldosterone can cause changes in your body that lead to heart failure. INSPRA is used to treat your heart failure to prevent worsening and reduce hospitalisations if you have: 1. had a recent heart attack, in combination with other drugs that are used to treat your heart failure, or 2. have persistent, mild symptoms despite the treatment you have been receiving so far. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE INSPRA DO NOT TAKE INSPRA if you are allergic to eplerenone or any of the other ingredients of this medicine (listed in section 6) if you have high levels of potassium in your blood (hyperkalemia) if you are taking groups of drugs which help you to excrete excessive body fluid (potassium sparing diuretics) if you have severe kidney Прочитајте комплетан документ
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Inspra 50mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 50mg of eplerenone. Excipient with known effect: lactose monohydrate For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet _Product imported from Spain:_ Yellow, film-coated tablet, marked with 'NSR' over '50' on one side of the tablet and plain on the reverse. 4 CLINICAL PARTICULARS As per PA0822/020/002 5 PHARMACOLOGICAL PROPERTIES As per PA0822/020/002 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Tablet Core Lactose monohydrate Microcrystalline cellulose (E460) Croscarmellose sodium (E468) Hypromellose (E464) Sodium lauryl sulphate Talc (E553b) Magnesium stearate (E470b) Tablet coating _Opadry yellow:_ Hypromellose (E464) Titanium dioxide (E171) Macrogol 400 Polysorbate 80 (E433) Iron oxide yellow (E172) Iron oxide red (E172) 6.2 INCOMPATIBILITIES Not applicable. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _1_ _1_ _/_ _0_ _6_ _/_ _2_ _0_ _1_ _5_ _C_ _R_ _N_ _ _ _2_ _1_ _6_ _1_ _9_ _3_ _0_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 6.3 SHELF LIFE The shelf life expiry date of this product is the date shown on the blister strips and outer carton of the product as marketed in the country of origin. 6.4 SPECIAL PRECAUTIONS FOR STORAGE No special precautions for storage. 6.5 NATURE AND CONTENTS OF CONTAINER Cardboard outer containing blister strips. Pa Прочитајте комплетан документ